Browsing Tag
Lupin Limited
41 posts
Lupin to launch India’s first green inhalers with Honeywell’s Solstice Air: Can pharma go climate-smart?
Lupin is partnering with Honeywell to launch India’s first low-GWP inhalers using Solstice Air propellant. Find out how it’s reshaping respiratory care.
Lupin gets US FDA nod for generic Xarelto; Eyes $8bn anticoagulant market
Lupin wins FDA approval for generic Xarelto, unlocking access to a USD 8 billion U.S. anticoagulant market. Find out what this means for investors and rivals.
Lupin reports robust FY25 earnings with 71% profit growth and 600% dividend payout
Lupin posts 71% profit growth in FY25 with 600% dividend and strong U.S. performance. Find out how the pharma major is transforming its global footprint.
Lupin receives US FDA nod for Nagpur injectable facility manufacturing drug-device combinations
Lupin secures US FDA EIR for its Nagpur injectables facility, boosting export potential and complex generics expansion. Read how this impacts global strategy.
Lupin Digital Health expands cardiac care with home-based recovery guide
Discover how Lupin Digital Health’s Post-Procedure Home-Based Care Guide is transforming cardiac recovery with expert-driven, structured home-care solutions.
Lupin shocks the market with massive profit gains in Q3 FY2025—here’s what you need to know
Lupin Limited, a leading global pharmaceutical company, has reported strong financial results for the third quarter of fiscal…
Lupin acquires diabetes trademarks from Boehringer Ingelheim to bolster treatment portfolio
Lupin Limited, a global pharmaceutical leader based in Mumbai, has announced the acquisition of three anti-diabetes trademarks—GIBTULIO, GIBTULIO…
Lupin partners with Takeda to launch novel gastrointestinal drug Vonoprazan in India
In a significant development, Lupin Limited, a global pharmaceutical leader, announced a non-exclusive patent licence agreement with Takeda…
New drug launch sends Lupin shares soaring to record highs! Find out what’s next
Lupin Limited, a global pharmaceutical major, has seen its share price reach a 52-week high following the launch…
Lupin Limited sees explosive profit surge in Q1 FY2025
Lupin Limited has reported a remarkable financial performance for the quarter ending June 30, 2024. The pharmaceutical giant’s…